PROJECT REPORT

JSTAR- HEALTHCARE
For the People
By the People
To the People
Caring Peoples life
Inspiring New Era in life
sciences"

12/14/2012

Confidentiality Agreement
The undersigned reader acknowledges that the information provided by _______________ in
this business plan is confidential; therefore, reader agrees not to disclose it without the express
written permission of _______________.
It is acknowledged by reader that information to be furnished in this business plan is in all
respects confidential in nature, other than information which is in the public domain through
other means and that any disclosure or use of same by reader, may cause serious harm or
damage to _______________.
Upon request, this document is to be immediately returned to _______________.
___________________
Signature
___________________
Name (typed or printed)
___________________
Date
This is a business plan. It does not imply an offering of securities.

Table of Contents

1.0 Executive Summary .................................................................................................................... 1

1.1 Objectives.................................................................................................................................... 1
1.2 Mission .......................................................................................................................................... 2
1.3 Keys to Success ........................................................................................................................ 2
2.0 Company Summary ..................................................................................................................... 2
2.1 Company Ownership ............................................................................................................... 3
2.2 Start-up Summary ................................................................................................................... 3
3.0 Products ........................................................................................................................................... 4
4.0 Market Analysis Summary ........................................................................................................ 4
4.1 Market Segmentation ............................................................................................................. 5
4.2 Target Market Segment Strategy ...................................................................................... 5
5.0 Strategy and Implementation Summary..................................................... 5
5.1 Competitive Edge ..................................................................................................................... 5
5.2 Marketing Strategy .................................................................................................................. 6
5.3 Sales Strategy ........................................................................................................................... 6
6.0 Management Summary .............................................................................................................. 8
7.1 Start-up Funding .................................................................................................................... 10
7.3 Break-even Analysis.............................................................................................................. 11
7.5 Projected Cash Flow .............................................................................................................. 15
7.6 Projected Balance Sheet ...................................................................................................... 16
7.7 Business Ratio ...18
7.8 Fund Flow Statement...19

Page 1

Jstar Healthcare Private Limited

1.0 Executive Summary

The Company is intending to manufacture Non Alcoholic Energy Drink under the Brand name of
MARS - 180 non alcoholic energy drink. as an instant energy booster health drink and pain
killing Plasters used for fighting against pain and fractures. The said product will be procured
from overseas ( Malaysia & Germany ). This will be imported in bulk reprocessed packed in
India.
The Non Alcoholic Energy Drinks will be manufactured in INDIA an indigenous product will be
penetrated through Distributors & Channel partners all over south India.
The Plasters will be ethically promoted through Doctors ( General Practitioners, Orthopaedics
and Gynaecologists and will be distributed through pharmaceutical distributors all over
Karnataka, Tamil Nadu, Andhra Pradesh and Kerala.
The product will be exclusively imported by the Company and the Company is getting into
contract with the exporter for supply exclusively for the Company and not to others in India.
1.1 Objectives
The process of importing Energy Drink is incurring huge hidden expenses with customs, PHO &
other Government Authorities which are in turn curtailing the companys profits and to sell at
an higher cost to focus as a premium segment price tag our aim is to target on the middle
income group and the product reach should go to the mass segment at an economical
affordable price tag.
Keeping in the view the promoter has come with their own corporate identity known as M/s
JSTAR HEALTHCARE PRIVATE LIMITED having its registered office at Bangalore (hereinafter
referred to as Company). The Company also have got a strong dealers supporting in various
places of South-India to market the product.
JSTAR will indigenously manufacture Healthcare range of products such as Health drinks, Non
Alcoholic energy drinks and importing pain killing plasters, Pain Killer Oils, pain killing Ointment

Page 1

Jstar Healthcare Private Limited

to ensure the reach of the product to mass segment and its future penetration of the products
at an economical prices tag.
JSTAR Healthcare private Limited will import these semi-raw products from overseas sourcing
from Asian and European markets.

1.2 Mission
JSTAR will indigenously manufacture Healthcare range of products such as Health drinks, Non Alcoholic
energy drinks and importing pain killing plasters, Pain Killer Oils, pain killing Ointment to ensure the reach of
the product to mass segment and its future penetration of the products at an economical prices tag.
To become a premier eye care provider by extending quality healthcare services to the next generation.
1.3 Keys to Success
There are five generally accepted keys to success in the our industry:
1. Wide range of products
2. Superior quality raw materials
3. Reliable delivery network
4. Competitive prices
5. Customer focused approach
6. No burden of Customs to Customers.
2.0 Company Summary
In leading a team from front achieving 100 % sales and heading a profit orientation in
managing Sales team motivating creating innovate Ideas in achieving the sales target.
Possessing a high level management position as National Sales Manager lead a team of 12
Regional sales Manager 3 Zonal Managers and 40 Sales representative leading from front in
achieving the organizational objectives.
Having good 10 years exposure in +\ Industry gained confidence and contacts of General
Practitioners, Orthopedicians, Pediatricians & Gynecologists.
In 2006 joined Atrimed Pharmaceuticals Pvt Limited as G M Sales & Marketing assigned for
Export Market exporting Ayurvedic products to Singapore, Malaysia, South African markets
setting up market segments to develop the sales overseas.
Established Mars Inc. as a proprietary organization in 2008 - importing, distributing of
Hospitality, Non Alcoholic Energy Drink, Confectionerys and stockiest for Dabur India Limited,
Olivia Cosmetics Pvt Limited, VLCC cosmetics in Bangalore. Strengthening the distribution
network in South India having 6 Distributing Channels in Karnataka, 4 distributing Channels in
Tamil nadu, 2 Distributing Channel in kerala and also expanding the network in Goa, Gujarat &
Maharastra for Non Alcoholic Energy Drink.

Page 2

Jstar Healthcare Private Limited

2.1 Company Ownership

JstarHealthcare Private Limited is incorporated as a Private limited liability company, in the
state of Karnataka and its registered office is in Viveknagar, Bangalore. The Company
shareholders are founders , Mr. Jyotheshwar Sharavana and Mrs.Thulasi Rani Shravana

2.2 Start-up Summary

COST OF THE PROJECT
Sl No.

Descriptions

Amount (in Rs. lacs)

Energy Drink Pain Relief Plasters
Total

Land

500

200

700

Office equipment

100

50

150

Plant & Machinery

125

25

150

Building

75

50

125

800

325

1,125

300

100

400

30

15

45

Brand Ambasador

200

100

300

Marketing

100

50

150

630

265

895

1,430

590

2,020

Total A
Preliminary Expense
Advertisements
Statutory Registrations

Total B
Total A+B

Page 3

Jstar Healthcare Private Limited

3.0 Products
The company is into 2 verticals which are as follows :
1. Energy Drinks
2. Ayurvedic Products

The products in the each verticles is as follows :

In Energy Drinks:

Health drinks
Non Alcoholic Energy Drinks
Diabetic tea

In Ayurvedic products:

Pain Relief plasters

Pain Relief oils
Pain Relief ointments
Derma care product

4.0 Market Analysis Summary

Mr. Jyotheshwar Sharavana standing in the position of Director Marketing has already under
gone talks with around 2,000 doctors and prepared a list of 43,000 doctors in Karnataka.
The overall discussions with his associates he has got some positive assurance of achieving the
targets as mentioned in the financial projections for the Company.
The product will be entering in the market through distribution channels available in the
Company.
The product will be made available in all leading medical stores and will be sold against
prescription only. Hence the product will be promoted to all the doctors and will bring the
awareness about the speciality and usefulness about the product.
Already with the contacts available with the promoter some doctors have been called for and
they are fully satisfied about the project and have promised their co-operation in the promotion
of projects concerning the usefulness to patients by using this method against the traditional
methods.
The cost of the product has also been placed in such a manner that it is worth and cheaper than
other methods prevailing in the markets which will in turn help the Company in reaching all
classes of community. Hence the volume of business will not be in stake.
Looking at the progress of the Company about the product, their study about the Market, their
collaborations and their tie-ups with distributors it produces the large output of sale of the
product.
The product is also the monopoly in the Industry. Hence the demand will not be a constraint.

Page 4

Jstar Healthcare Private Limited

The ED has maintained a extensive track record in with all dealers and suppliers of
Pharmaceutical, Ayurvedic & Healthcare products.
ED has undergone a complete study on the customer behaviour pattern and their state of mind
for the Pharmaceutical, Ayurvedic & Healthcare products. He has done undergone study of
various types of diseases disturbing the man kind and has got extensive contacts of most of
doctors, council members of medical institutes.
Looking at the growth in the Pharmaceutical industry products and with is contacts all over the
globe has come out with some products which are used as plasters for fractures. Evaluating the
proposal it has been found the product is unique in the market and very competitive than other
traditional methods being followed in India to fight against fractures.

4.1 Market Segmentation

The products are targeted to Mass public and market penetration is to be explored in all the
segments
4.2 Target Market Segment Strategy
The Energy Drinks has maintained a extensive track record in with all dealers and suppliers of
Pharmaceutical, Ayurvedic & Healthcare products.
ED has undergone a complete study on the customer behaviour pattern and their state of mind
for the Pharmaceutical, Ayurvedic & Healthcare products. He has done undergone study of
various types of diseases disturbing the man kind and has got extensive contacts of most of
doctors, council members of medical institutes.
Looking at the growth in the Pharmaceutical industry products and with is contacts all over the
globe has come out with some products which are used as plasters for fractures. Evaluating the
proposal it has been found the product is unique in the market and very competitive than other
traditional methods being followed in India to fight against fractures.

5.0 Strategy and Implementation Summary

5.1 Competitive Edge
The manufacturing & Packing unit is setting up at Dharmapuri Palacode Tamil Nadu and will
be marketed & distributed from this destination to all over India.
Basically low cost of labour in Tamil Nadu compared to other places in South India and the
distributing cost to south India can be minimized in saving on transporting of finished goods.
Availing subsidy on power

Page 5

Jstar Healthcare Private Limited

5.2 Marketing Strategy

The ED has maintained a extensive track record in with all dealers and suppliers of
Pharmaceutical, Ayurvedic & Healthcare products.

ED has undergone a complete study on the customer behaviour pattern and their state of mind
for the Pharmaceutical, Ayurvedic & Healthcare products. He has done undergone study of
various types of diseases disturbing the man kind and has got extensive contacts of most of
doctors, council members of medical institutes.

Looking at the growth in the Pharmaceutical industry products and with is contacts all over the
globe has come out with some products which are used as plasters for fractures. Evaluating
the proposal it has been found the product is unique in the market and very competitive than
other traditional methods being followed in India to fight against fractures.
5.3 Sales Strategy
For energy drinks the company is going to increase the sales in stage wise basis which is in line
with the production capacity and number of shifts of manufacturing.
The sale price to the wholesale distributor will be at 65 inclusive of CST and CENVAT. The
breakup of invoice of single unit is as follows :
Product

Qty

Rate

EnergyDrink

Excise @ 12.36%

Amount

56.72

56.72

12.36%

Total

63.72

CST @ 2%

2%

1.28

Total

65

The total sales in units is expected to be as follows :

Details
Energy Drinks units

2013-14

2014-15
27,64,800

2015-16
55,29,600

82,94,400

2016-17
2017-18
1,10,59,200
1,38,24,000

Page 6

Jstar Healthcare Private Limited

Also the Gross margin breakup for Energy Drink is as follows :

Energy Drink Breakup of Gross Margin

Details

Amount in Rs.

Raw Material

19.5

Labour

4.25

Power

Packing

CENVAT

Total Cost

37.75

Sale price to Distributer Excluding CST

63.73

Gross Margin per unit

25.98

Page 7

Jstar Healthcare Private Limited

5.3.1 Sales Forecast

Revenue

2013-14

2014-15

2015-16

2016-17

2017-18

Energy drink
Plaster

17,62,00,704
21,60,00,000

35,24,01,408
28,08,00,000

52,86,02,112
36,50,40,000

70,48,02,816
47,45,52,000

88,10,03,520
61,69,17,600

Turnover

63,74,21,904

1,02,50,48,808

1,44,47,92,212

1,90,62,87,066

2,42,20,58,805

4,00,00,00,000
3,50,00,00,000
3,00,00,00,000
2,50,00,00,000
2,00,00,00,000
1,50,00,00,000
1,00,00,00,000

Turnover
Plaster
Energy drink

50,00,00,000
-

6.0 Management Summary

Profile - Jyotheshvar Sharavana
A B.com /PG in sales and marketing from Mumbai. Started sales carrier in the 1985 as sales
representative for a proprietary organization for a period of 2 years.
Worked with M/s. HLL as Merchandising representative for period of 3 years at Chennai Head
Quarters from 16 .01.1987 31.12.1989
Worked with M/s. Toshiba Anand Batteries Limited a Multinational company as Area Sales
Manager leading a team of representatives proving consistence performance from 1990 -1995.
In 1995 Entered the Pharmaceutical Industry worked with M/s. Gentech Labs Limited Lyka
Group of companies served the group till 2002 under different Managerial level gaining healthy
goodwill in Pharmaceutical, Healthcare, Herbal & Ayurvedic products and life saving drugs for
human cause. Achieved high honors from the broad of Directors in the last assigned company
M/s. Gentech Labs Limited Mumbai.

Page 8

Jstar Healthcare Private Limited

Profile : Mrs.Thulasi Rani Shravana

A B.A. Graduate started professional career with Ross Murarka Finance Limited - Mumbai as
Secretary and Manager administration heading Bangalore Branch motivating / Co-ordinating
team of admin staff, sales representative, liasioning with Public limited companies and
corporate sectors. Served the organization for more than 10 years. 1987 1997
Worked with Manipal Heart Foundation heading as secretary in assisting OT department from
1999 2006
Established as entrepreneur in forming a Company in the name of INDOTECH MICRON
DEVICES. Importing Hospitality range of products Since 2008.

Page 9

Jstar Healthcare Private Limited

7.0 Financial Plan

7.1 Start-up Funding
COST OF THE PROJECT
Sl No.

Descriptions

Amount (in Rs. lacs)

Energy Drink Pain Relief Plasters
Total

Land

500

200

700

Office equipment

100

50

150

Plant & Machinery

125

25

150

Building

75

50

125

800

325

1,125

300

100

400

30

15

45

Brand Ambasador

200

100

300

Marketing

100

50

150

630

265

895

1,430

590

2,020

Total A
Preliminary Expense
Advertisements
Statutory Registrations

Total B
Total A+B

The Preliminary Expenses are provided seperately as these will be amortised in 3 years as their
benifits are assumed to be for over period of 3 years.
The Advertisment cost is arrived at cost incurred for making a TV commercial and having 10
min prime airtime on popular TV channel in south India.
The Brand Ambasador is chosen to be a former Cricketor and the cost is for 3 years.
7.2 Important Assumptions
The financial plan depends on important assumptions, most of which are shown below. The key
underlying assumptions are:
1. We assume a slow-growth economy, without major recession.
2. We assume of course that there are no unforeseen changes in technology to make
products immediately obsolete.
3. The Depreciation rates are as per the Income Tax rates.

Page 10

Jstar Healthcare Private Limited

4. The tax computed is as per the Income Tax rate of 30.90% applicable for AY 2013-14.
The same rate is taken for arriving at tax liability for all the projected years.
5. The Direct Labour charges ar as per the current market wages aplicable which is around
Rs. 7,500 per month per labour. As there are more orders the company will hire staff to
utilise the maximum possible machine capacity.
6. The inventory holding is assumed to be optimal at 30 days holding
7. The Term Loan to the company is at 16% p.a interest payable at every quarter and
there is a Board Resolution passed by the board member to the effect.
8. There is competiton and inflation expected in future year which will affect the gross
margin and net profit
9. The Receivable are taken at 2 months of Sales
10. The payable are taken at 2 months of cost of goods sold.

7.3 Break-even Analysis

Description

Amount in Rs. Lacs

Term Loan

2020

Cash Net Profit after Interest and Tax adding back Depreciation :
Year 1
Year 2
Year 3

443
1086
1742

Total

3271

Break-even for project is 2 years and 45 days

Page 11

Jstar Healthcare Private Limited

7.4 Projected Profit and Loss

Profit and Loss statement of Energy Drink Segment:
Details
Energy Drinks units

2013-14
2014-15
2015-16
2016-17
2017-18
27,64,800
55,29,600
82,94,400
1,10,59,200
1,38,24,000

Sale

17,62,00,704

35,24,01,408

52,86,02,112

70,48,02,816

88,10,03,520

COS

10,43,71,200

20,87,42,400

31,31,13,600

41,74,84,800

52,18,56,000

7,18,29,504

14,36,59,008

21,54,88,512

28,73,18,016

35,91,47,520

Telephone & Communication

Manpower
Consultancy & Regulatories
Transportation
Factory Maintenance

1,00,000
24,80,000
6,00,000
35,24,014
6,00,000

1,10,000
26,04,000
6,60,000
70,48,028
6,30,000

1,21,000
27,34,200
7,26,000
1,05,72,042
6,61,500

1,33,100
28,70,910
7,98,600
1,40,96,056
6,94,575

1,46,410
30,14,456
8,78,460
1,76,20,070
7,30,000

Operating Cost

73,04,014

1,10,52,028

1,48,14,742

1,85,93,241

2,23,89,396

6,45,25,490

13,26,06,980

20,06,73,770

26,87,24,775

33,67,58,124

Margin
Cost of Manufacturing

Net Profit of division

Page 12

Jstar Healthcare Private Limited

Profit and Loss statement of Pain Relief Plasters Segment:

Details
Ayurvedic Products

2013-14
2014-15
2015-16
2016-17
2017-18
90,00,000
1,17,00,000
1,52,10,000
1,97,73,000
2,57,04,900

Sale

21,60,00,000

28,08,00,000

36,50,40,000

47,45,52,000

61,69,17,600

COS

14,08,50,000

18,31,05,000

23,80,36,500

30,94,47,450

40,22,81,685

7,51,50,000

9,76,95,000

12,70,03,500

16,51,04,550

21,46,35,915

50,000
74,40,000
6,00,000
43,20,000
6,00,000

55,000
78,12,000
6,60,000
56,16,000
6,30,000

60,500
82,02,600
7,26,000
73,00,800
6,61,500

66,550
94,32,990
8,34,900
83,95,920
7,60,725

73,205
1,08,47,939
9,60,135
96,55,308
8,74,834

Operating Cost

1,30,10,000

1,47,73,000

1,69,51,400

1,94,91,085

2,24,11,420

Net Profit before Depreciation

and Amortisation

6,21,40,000

8,29,22,000

11,00,52,100

14,56,13,465

19,22,24,495

Margin
Cost of Manufacturing
Communication
Manpower
Consultancy & Regulatories
Transportation
Factory Maintenance

Consolidated Profit and Loss :

Details
Energy Drink
Pain Refief Plasters

2013-14

Total Profit

6,45,25,490
6,21,40,000

2014-15
2015-16
2016-17
2017-18
13,26,06,980
20,06,73,770
26,87,24,775
33,67,58,124
8,29,22,000
11,00,52,100
14,56,13,465
19,22,24,495

12,66,65,490

21,55,28,980

31,07,25,870

41,43,38,240

52,89,82,619

Depreciation
Statutor registration & Compliances
Marketing
Interest

50,00,000
45,00,000
2,83,33,333
3,20,00,000

43,87,500
2,83,33,333
3,20,00,000

38,53,125
2,83,33,333
3,20,00,000

33,86,531
2,83,33,333

29,78,789
2,83,33,333

Total A

6,98,33,333

6,47,20,833

6,41,86,458

3,17,19,864

3,13,12,122

Net Profit before Tax

5,68,32,157

15,08,08,147

24,65,39,412

38,26,18,375

49,76,70,497

Tax

1,75,61,136

4,65,99,717

7,61,80,678

11,82,29,078

15,37,80,184

Net Profit after Tax

3,92,71,021

10,42,08,430

17,03,58,734

26,43,89,297

34,38,90,313

Page 13

Jstar Healthcare Private Limited

Page 14

Jstar Healthcare Private Limited

7.5 Projected Cash Flow

Description

2013-14

2014-15

2015-16

2016-17

2017-18

3,92,71,021

10,42,08,430

17,03,58,734

26,43,89,297

34,38,90,313

50,00,000

43,87,500

38,53,125

33,86,531

29,78,789

4,42,71,021

10,85,95,930

17,42,11,859

26,77,75,829

34,68,69,102

Advances & Prepayments

Accounts Receivables
Inventory
Accounts payables and accruals
Creditors for Exp
Provisons

(10,00,000)
(7,71,09,836)
(4,08,70,200)
2,04,35,100
16,92,835
1,75,61,136

(2,84,23,732)
(2,44,37,700)
1,22,18,850
4,59,251
2,90,38,581

(4,34,06,784)
(2,65,50,450)
1,32,75,225
4,95,093
2,95,80,961

(20,00,00,000)
(4,76,18,784)
(2,92,97,025)
1,46,48,513
5,26,515
4,20,48,400

(5,30,94,384)
(3,28,67,573)
1,64,33,786
5,59,707
3,55,51,106

Net Change in Working Capital

(7,92,90,965)

(1,11,44,750)

(2,66,05,955)

(21,96,92,381)

(3,34,17,357)

Cash Flow from Operating Activites(3,50,19,944)

9,74,51,180

14,76,05,904

4,80,83,448

31,34,51,745

Cash Flow from Investing Activites

Purchase of Fixed Assets (16,91,66,666)

2,83,33,333

2,83,33,333

(20,20,00,000)
-

Net Profit
Depreciation
Cash Profit
Changes in Working Capital

Cash Flow from Finance Activites

1,00,00,000
Capital Introduced
20,20,00,000
Term Loan
Loan from Directors
Dividend paid
Repayment - Principal
Term Deposits
Net Cash Flow during the Year
Opening Cash & Bank Balance
Cash & Bank at the end
of the year

78,13,390
-

78,13,390

12,57,84,513

(2,60,60,763)

4,80,83,448

31,34,51,745

78,13,390

13,35,97,902

10,75,37,139

15,56,20,587

13,35,97,902

10,75,37,139

15,56,20,587

46,90,72,332

Page 15

Jstar Healthcare Private Limited

Cash Flow from Operating Activites

70,00,00,000
60,00,00,000
50,00,00,000
40,00,00,000
Cash Flow from Operating
Activites

30,00,00,000
20,00,00,000
10,00,00,000
-

7.6 Projected Balance Sheet

Liabilities
Share Capital
Paid up Capital
Reserves & Surplus
Term Loan
Current Liabilites
Tax Provision
Creditors for Exp
Sundry Creditors (Trade)

2013-14

2014-15

2015-16

2016-17

2017-18

1,00,00,000

1,00,00,000

1,00,00,000

1,00,00,000

1,00,00,000

3,92,71,021

14,34,79,451

31,38,38,185

57,82,27,482

92,21,17,795

20,20,00,000

20,20,00,000

1,75,61,136
16,92,835
2,04,35,100

4,65,99,717
21,52,086
3,26,53,950

7,61,80,678
26,47,179
4,59,29,175

11,82,29,078
31,73,694
6,05,77,688

15,37,80,184
37,33,401
7,70,11,474

29,09,60,091

43,68,85,203

44,85,95,216

77,02,07,941

1,16,66,42,854

Total
Assets
Cash on hand
Cash at Bank
Fixed Assets
Tangible
Non- tangable
Loans and Advances
Trade Debtors
Stock in hand

5,00,000
73,13,390

15,00,000
13,20,97,902

15,00,000
10,60,37,139

15,00,000
15,41,20,587

15,00,000
46,75,72,332

10,75,00,000
5,66,66,666
10,00,000
7,71,09,836
4,08,70,200

10,31,12,500
2,83,33,333
10,00,000
10,55,33,568
6,53,07,900

9,92,59,375
10,00,000
14,89,40,352
9,18,58,350

9,58,72,844
20,10,00,000
19,65,59,136
12,11,55,375

9,28,94,055
20,10,00,000
24,96,53,520
15,40,22,948

Total

29,09,60,091

43,68,85,203

44,85,95,216

77,02,07,941

1,16,66,42,854

Page 16

Jstar Healthcare Private Limited

7.7 Business Ratio

S. No For year ended / ending
September 30,

2013-14
Projection

2014-15
Projection

2015-16
Projection

2016-17
Projection

Net Sales

39,22,00,704

63,32,01,408

89,36,42,112

1,17,93,54,816

P B ILD T

9,38,32,157

18,71,95,647

28,23,92,537

38,60,04,907

PBT

5,68,32,157

15,08,08,147

24,65,39,412

38,26,18,375

P AT

3,92,71,021

10,42,08,430

17,03,58,734

26,43,89,297

Net Cash Accruals

4,42,71,021

10,85,95,930

17,42,11,859

26,77,75,829

P B I L D T/ Net Sales (%)

23.92%

29.56%

31.60%

32.73%

PAT/ Net Sales (%)

10.01%

16.46%

19.06%

22.42%

Dividend/PAT (%)

Gross Block

11,25,00,000

10,75,00,000

10,31,12,500

9,92,59,375

10

Net Block

10,75,00,000

10,31,12,500

9,92,59,375

9,58,72,844

11

Paid up Capital

1,00,00,000

1,00,00,000

1,00,00,000

1,00,00,000

12

Tangible Networth (TNW)

12,51,46,118

24,15,670

24,82,283

13

Group Invetsments

14

Adjusted T N W

15

(73,95,645)
-

(73,95,645)

12,51,46,118

LTD /T NW

(27.31)

1.61

16

DFS/TNW

17

TO L/TNW

-32.68

18

Current Assets

19

24,15,670

2.26

24,82,283

51.64

73.31

12,67,93,425

30,54,39,370

34,93,35,841

67,43,35,098

Current Liabilities

3,96,89,071

8,14,05,753

12,47,57,032

18,19,80,459

20

Net Working Capital

8,71,04,355

22,40,33,618

22,45,78,810

49,23,54,638

21

Current Ratio

3.19

3.75

2.80

3.71

45.65%

55.88%

86.01%

65.05%

2.93

5.85

8.82

#DIV/0!

5.85

8.82

#DIV/0!

Other Indicators
22

R O C E (%)

23

Interest Coverage Ratio

24

DSCR

Fund Flow Analysis

Year Ended / Ending September 30,
Long Term Sources
Long Term uses
Surplus/Deficit
Surplus / Incremental build up of current assets (%)

2014-15

2015-16

13,69,29,263

20,25,45,192

20,20,00,000

13,69,29,263

5,45,192

140.90%

14.37%

2016-17
26,77,75,829
26,77,75,829
93.03%

Page 17

Jstar Healthcare Private Limited

7.8 Fund Flow Statement

Amounts in Rs.
Next Year
Year

1. SOURCES
a. Net Profit
b. Depreciation
c. Increase in Capital
d. Increase in Term Liabilities
(including Public Deposits)
e. Decrease in
i.
Fixed Assets
ii. Other non-current Assets
f.
Others
g. TOTAL
2. USES
a. Net loss
b. Decrease in Term Liabilities
(including Public Deposits)
c. Increase in
i.
Fixed Assets
ii. Other non-current Assets
d. Dividend Payments
e. Others
f.
TOTAL
3. Long Term Surplus (+) / Deficit (-) [1-2]
4. Increase/decrease in current assets
* (as per details given below)
5. Increase/decrease in current liabilities
other than bank borrowings
6. Increase/decrease in working capital gap
7. Net Surplus / Deficit (-) [3-6]
8. Increase/decrease in bank borrowings
9. Increase/decrease in NET SALES

Projections

Projections

Projections

Projections

2014-15

2015-16

2016-17

2017-18

10,42,08,430
(6,12,500)
-

17,03,58,734 26,43,89,297 34,38,90,313

(5,34,375)
(4,66,594)
(4,07,742)
-

50,00,000
2,83,33,333
13,69,29,263

43,87,500
2,83,33,333
20,25,45,192

38,53,125

33,86,531

0
26,77,75,829

34,68,69,102

20,20,00,000

0
0

20,20,00,000

13,69,29,263

5,45,192

26,77,75,829

34,68,69,102

17,86,45,945

4,38,96,471

32,49,99,257

39,94,13,702

4,33,51,279
5,72,23,428
5,45,192 26,77,75,829
(0)
26,04,40,704 28,57,12,704

5,25,44,600
34,68,69,102
0
31,85,66,304

4,17,16,682
13,69,29,263
24,10,00,704

* Break up of item-4
i. Increase/decrease in Raw Materials
2,44,37,700
ii. Increase/decrease in Stocks-in-Process
iii. Increase/decrease in Finished Goods
iv. Increase/decrease in Receivables
a) Domestic
2,66,171
b) Export
v. Increase/decrease in Stores & Spares
vi. Increase/decrease in other current assets
15,39,42,074
TOTAL 17,86,45,945

2,65,50,450
-

2,92,97,025
-

3,28,67,573
-

6,98,745
1,66,47,276
4,38,96,471

5,00,000
29,52,02,232
32,49,99,257

5,23,875
36,60,22,254
39,94,13,702

Page 18

Appendix

Page 1